-
Je něco špatně v tomto záznamu ?
Gallic acid-based indanone derivative interacts synergistically with tetracycline by inhibiting efflux pump in multidrug resistant E. coli
GR. Dwivedi, N. Tiwari, A. Singh, A. Kumar, S. Roy, AS. Negi, A. Pal, D. Chanda, A. Sharma, MP. Darokar,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
ProQuest Central
od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 1999-12-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-01-01 do Před 1 rokem
- MeSH
- antibakteriální látky farmakologie MeSH
- aplikace orální MeSH
- Escherichia coli účinky léků MeSH
- indany aplikace a dávkování škodlivé účinky farmakologie MeSH
- inhibitory enzymů farmakologie MeSH
- kyselina gallová aplikace a dávkování škodlivé účinky farmakologie MeSH
- makrofágy účinky léků MeSH
- mikrobiální testy citlivosti MeSH
- modely nemocí na zvířatech MeSH
- myši MeSH
- nežádoucí účinky léčiv MeSH
- septický šok prevence a kontrola MeSH
- simulace molekulového dockingu MeSH
- synergismus léků * MeSH
- tetracyklin farmakologie MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The purpose of the present study was to study the synergy potential of gallic acid-based derivatives in combination with conventional antibiotics using multidrug resistant cultures of Escherichia coli. Gallic acid-based derivatives significantly reduced the MIC of tetracycline against multidrug resistant clinical isolate of E. coli. The best representative, 3-(3',4,'5'-trimethoxyphenyl)-4,5,6-trimethoxyindanone-1, an indanone derivative of gallic acid, was observed to inhibit ethidium bromide efflux and ATPase which was also supported by in silico docking. This derivative extended the post-antibiotic effect and decreased the mutation prevention concentration of tetracycline. This derivative in combination with TET was able to reduce the concentration of TNFα up to 18-fold in Swiss albino mice. This derivative was nontoxic and well tolerated up to 300 mg/kg dose in subacute oral toxicity study in mice. This is the first report of gallic acid-based indanone derivative as drug resistance reversal agent acting through ATP-dependent efflux pump inhibition.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17000785
- 003
- CZ-PrNML
- 005
- 20170112120847.0
- 007
- ta
- 008
- 170103s2016 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00253-015-7152-6 $2 doi
- 024 7_
- $a 10.1007/s00253-015-7152-6 $2 doi
- 035 __
- $a (PubMed)26658982
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Dwivedi, Gaurav Raj $u Biotechnology Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Near Kukrail Picnic Spot, P.O. CIMAP, Lucknow, 226015, India. School of Environmental Science, Babasaheb Bhim Rao Ambedkar University, Lucknow, 226025, UP, India.
- 245 10
- $a Gallic acid-based indanone derivative interacts synergistically with tetracycline by inhibiting efflux pump in multidrug resistant E. coli / $c GR. Dwivedi, N. Tiwari, A. Singh, A. Kumar, S. Roy, AS. Negi, A. Pal, D. Chanda, A. Sharma, MP. Darokar,
- 520 9_
- $a The purpose of the present study was to study the synergy potential of gallic acid-based derivatives in combination with conventional antibiotics using multidrug resistant cultures of Escherichia coli. Gallic acid-based derivatives significantly reduced the MIC of tetracycline against multidrug resistant clinical isolate of E. coli. The best representative, 3-(3',4,'5'-trimethoxyphenyl)-4,5,6-trimethoxyindanone-1, an indanone derivative of gallic acid, was observed to inhibit ethidium bromide efflux and ATPase which was also supported by in silico docking. This derivative extended the post-antibiotic effect and decreased the mutation prevention concentration of tetracycline. This derivative in combination with TET was able to reduce the concentration of TNFα up to 18-fold in Swiss albino mice. This derivative was nontoxic and well tolerated up to 300 mg/kg dose in subacute oral toxicity study in mice. This is the first report of gallic acid-based indanone derivative as drug resistance reversal agent acting through ATP-dependent efflux pump inhibition.
- 650 _2
- $a aplikace orální $7 D000284
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 12
- $a synergismus léků $7 D004357
- 650 _2
- $a nežádoucí účinky léčiv $7 D064420
- 650 _2
- $a inhibitory enzymů $x farmakologie $7 D004791
- 650 _2
- $a Escherichia coli $x účinky léků $7 D004926
- 650 _2
- $a kyselina gallová $x aplikace a dávkování $x škodlivé účinky $x farmakologie $7 D005707
- 650 _2
- $a indany $x aplikace a dávkování $x škodlivé účinky $x farmakologie $7 D007189
- 650 _2
- $a makrofágy $x účinky léků $7 D008264
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a simulace molekulového dockingu $7 D062105
- 650 _2
- $a septický šok $x prevence a kontrola $7 D012772
- 650 _2
- $a tetracyklin $x farmakologie $7 D013752
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Tiwari, Nimisha $u Biotechnology Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Near Kukrail Picnic Spot, P.O. CIMAP, Lucknow, 226015, India.
- 700 1_
- $a Singh, Aastha $u Chemical Sciences Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Near Kukrail Picnic Spot, P.O. CIMAP, Lucknow, 226015, India.
- 700 1_
- $a Kumar, Akhil $u Biotechnology Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Near Kukrail Picnic Spot, P.O. CIMAP, Lucknow, 226015, India.
- 700 1_
- $a Roy, Sudeep $u Biotechnology Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Near Kukrail Picnic Spot, P.O. CIMAP, Lucknow, 226015, India. Department of Biomedical Engineering, Faculty of Electronics and Communication, Brno University of Technology, Antonínská 548/1, 60190, Brno, Czech Republic.
- 700 1_
- $a Negi, Arvind Singh $u Chemical Sciences Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Near Kukrail Picnic Spot, P.O. CIMAP, Lucknow, 226015, India. as.negi@cimap.res.in.
- 700 1_
- $a Pal, Anirban $u Biotechnology Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Near Kukrail Picnic Spot, P.O. CIMAP, Lucknow, 226015, India.
- 700 1_
- $a Chanda, Debabrata $u Biotechnology Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Near Kukrail Picnic Spot, P.O. CIMAP, Lucknow, 226015, India.
- 700 1_
- $a Sharma, Ashok $u Biotechnology Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Near Kukrail Picnic Spot, P.O. CIMAP, Lucknow, 226015, India.
- 700 1_
- $a Darokar, Mahendra P $u Biotechnology Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Near Kukrail Picnic Spot, P.O. CIMAP, Lucknow, 226015, India. mp.darokar@cimap.res.in.
- 773 0_
- $w MED00000493 $t Applied microbiology and biotechnology $x 1432-0614 $g Roč. 100, č. 5 (2016), s. 2311-25
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26658982 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170103 $b ABA008
- 991 __
- $a 20170112120947 $b ABA008
- 999 __
- $a ok $b bmc $g 1179925 $s 961352
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 100 $c 5 $d 2311-25 $e 20151212 $i 1432-0614 $m Applied microbiology and biotechnology $n Appl Microbiol Biotechnol $x MED00000493
- LZP __
- $a Pubmed-20170103